Jones Ryan, Libby Bruce, Showalter Shayna L, Brenin David R, Wilson David D, Schroen Anneke, Morris Monica, Reardon Kelli A, Morrison John, Showalter Timothy N
Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, VA.
Division of Surgical Oncology, Department of Surgery, University of Virginia School of Medicine, Charlottesville, VA.
Brachytherapy. 2014 Sep-Oct;13(5):502-7. doi: 10.1016/j.brachy.2014.04.005. Epub 2014 Jun 3.
At our institution, the availability of a shielded procedure room with in-room CT-on-rails imaging allows for the exploration of a high-dose-rate (HDR) brachytherapy approach for breast intraoperative radiation therapy (IORT). We hypothesize that HDR brachytherapy will permit a higher prescription dose without increasing toxicity. In this study, we compare the dosimetry of intraoperative HDR brachytherapy, using multilumen balloon applicator, to IORT with a 50 kV source and then select a prescription dose for a subsequent clinical trial.
The CT scans of 14 patients who had previously received multilumen balloon-based breast brachytherapy were replanned to a standard prescription to the target volume. The same 14 cases were planned to the specifications of a 50 kV x-ray system. Uniform volume optimization and prescription doses were used to permit direct comparisons. All plans were evaluated for the dose homogeneity index, tumor coverage, and dose to normal tissues, including skin, ribs, and heart (for left breast plans).
The HDR brachytherapy plans were superior to 50 kV superficial photon plans for IORT in all dosimetric parameters except for the heart and rib dosimetric parameters. Prescription dose of 12.5 Gy to the planning target volume for evaluation yielded a dose to 95 percent of the balloon surface of 19.7 Gy.
Image-guided HDR intraoperative brachytherapy with a multilumen balloon applicator provides superior target volume coverage compared with 50 kV photons, while maintaining doses within tolerance limits for normal tissues. An ongoing prospective clinical trial will evaluate the safety and feasibility of this technique.
在我们机构,配备有室内轨道CT成像的屏蔽治疗室可用于探索高剂量率(HDR)近距离放射治疗用于乳腺术中放射治疗(IORT)的方法。我们假设HDR近距离放射治疗能够允许更高的处方剂量而不增加毒性。在本研究中,我们比较使用多腔球囊施源器的术中HDR近距离放射治疗与50 kV源的IORT的剂量学,然后为后续临床试验选择处方剂量。
对14例先前接受基于多腔球囊的乳腺近距离放射治疗的患者的CT扫描重新规划至标准的靶区处方剂量。对这14例相同病例按照50 kV X射线系统的规格进行计划。采用统一的体积优化和处方剂量以进行直接比较。评估所有计划的剂量均匀性指数、肿瘤覆盖率以及对正常组织的剂量,包括皮肤、肋骨和心脏(针对左侧乳腺计划)。
除心脏和肋骨剂量学参数外,HDR近距离放射治疗计划在所有剂量学参数方面均优于50 kV浅表光子IORT计划。对计划靶区评估的处方剂量为12.5 Gy时,球囊表面95%的剂量为19.7 Gy。
与50 kV光子相比,使用多腔球囊施源器的图像引导HDR术中近距离放射治疗可提供更好的靶区覆盖,同时将正常组织的剂量维持在耐受限度内。一项正在进行的前瞻性临床试验将评估该技术的安全性和可行性。